Arkolith/Insider Trading/GYRE/Form 4

Ma Songjiang

President, DirectorGYRE THERAPEUTICS, INC. (GYRE) · full profile →Form 4 · filed Feb 25, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$45K
Net Open-Market Flow
-$45K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2025Sell(S)187$11.52$2K2.9M
Feb 24, 2025Sell(S)2K$10.60$19K2.9M
Feb 21, 2025Sell(S)182$12.60$2K2.9M
Feb 21, 2025Sell(S)2K$11.84$22K2.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-005842) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML